(NASDAQ:YMTX) shares are up more than 40% in the pre-market on more than 23,000 trades on Acquisition news. Currently at $1.98

(NASDAQ:YMTX) shares are up more than 40% in the pre-market on more than 23,000 trades on Acquisition news. Currently at $1.98

Yumanity Therapeutics, Inc.(Yumanity) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced it has entered into definitive agreements for two strategic transactions.

https://sports.yahoo.com/yumanity-therapeutics-announces-definitive-agreements-103000748.html

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist